Tianjin, China

Junbin Zhang

This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Suzhou Ribo Life Science Company, Ltd.. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Junbin Zhang. Retrieved from https://idiyas.com/inventor/junbin-zhang-r2hconsc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Junbin Zhang: Innovator in Oligonucleotide Preparation

Introduction

Junbin Zhang is a notable inventor based in Tianjin, China. He has made significant contributions to the field of oligonucleotide synthesis. His innovative methods have the potential to enhance the efficiency of oligonucleotide production.

Latest Patents

Junbin Zhang holds a patent for a method of preparing oligonucleotides. This method involves reacting a compound of Formula (1) with a compound of Formula (2) in a liquid reaction medium under condensation reaction conditions. The result is the compound of Formula (3). The process utilizes 1-(2-mesitylenesulfonyl)-3-nitro-1H-1,2,4-triazole (MSNT) as a condensing agent. This technique allows for the large-scale synthesis of oligonucleotides in a liquid reaction medium.

Career Highlights

Junbin Zhang is currently employed at Suzhou Ribo Life Science Company, Ltd. His work focuses on advancing methodologies in the field of life sciences. His expertise in oligonucleotide synthesis has positioned him as a valuable asset in his company.

Collaborations

Some of Junbin Zhang's coworkers include Zhen Xi and Jinyu Huang. Their collaborative efforts contribute to the innovative research and development at Suzhou Ribo Life Science Company, Ltd.

Conclusion

Junbin Zhang's contributions to oligonucleotide preparation demonstrate his commitment to innovation in the life sciences sector. His patented method has the potential to significantly impact the efficiency of oligonucleotide synthesis.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…